Cargando…

Phase II Study of Cetuximab Plus Concomitant Boost Radiotherapy in Japanese Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

BACKGROUND: We investigated the tolerability of cetuximab plus radiotherapy in Japanese patients with untreated locally advanced squamous cell carcinoma of the head and neck. METHODS: Patients with epidermal growth factor receptor-expressing locally advanced squamous cell carcinoma of the head and n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okano, Susumu, Yoshino, Takayuki, Fujii, Masato, Onozawa, Yusuke, Kodaira, Takeshi, Fujii, Hirofumi, Akimoto, Tetsuo, Ishikura, Satoshi, Oguchi, Masahiko, Zenda, Sadamoto, de Blas, Barbara, Tahara, Makoto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638633/ https://www.ncbi.nlm.nih.gov/pubmed/23479383 http://dx.doi.org/10.1093/jjco/hyt030

Ejemplares similares

A Multicenter Phase II Trial of Docetaxel, Cisplatin, and Cetuximab (TPEx) Followed by Cetuximab and Concurrent Radiotherapy for Patients With Local Advanced Squamous Cell Carcinoma of the Head and Neck (CSPOR HN01: ECRIPS Study)
por: Zenda, Sadamoto, et al.
Publicado: (2019)

Induction chemotherapy with paclitaxel, carboplatin and cetuximab for locoregionally advanced nasopharyngeal carcinoma: A single-center, retrospective study
por: Takeshita, Naohiro, et al.
Publicado: (2022)

Platinum-based Chemotherapy Plus Cetuximab for the First-line Treatment of Japanese Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Results of a Phase II Trial
por: Yoshino, Takayuki, et al.
Publicado: (2013)

Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)
por: Tahara, Makoto, et al.
Publicado: (2015)

Post-mastectomy radiation therapy without usage of a bolus may be a reasonable option
por: Nakamura, Naoki, et al.
Publicado: (2017)

Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer
por: Nakamura, Naoki, et al.
Publicado: (2018)

The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer
por: Ueno, Takao, et al.
Publicado: (2018)

Impact of early radiological response evaluation on radiotherapeutic outcomes in the patients with nasal cavity and paranasal sinus malignancies
por: Hojo, Hidehiro, et al.
Publicado: (2012)

Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and Neck
por: Enokida, Tomohiro, et al.
Publicado: (2018)

A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients
por: Zenda, Sadamoto, et al.
Publicado: (2016)

Incidence and Risk Factors of Hypomagnesemia in Head and Neck Cancer Patients Treated with Cetuximab
por: Enokida, Tomohiro, et al.
Publicado: (2016)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Combination Treatment With Paclitaxel, Carboplatin, and Cetuximab (PCE) as First-Line Treatment in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma
por: Ueda, Yuri, et al.
Publicado: (2020)

Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer
por: Nakamura, Masaki, et al.
Publicado: (2018)

Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK
por: Uozumi, Shinya, et al.
Publicado: (2018)

Feasibility of Cisplatin/5-Fluorouracil and Panitumumab in Japanese Patients with Squamous Cell Carcinoma of the Head and Neck
por: Tahara, Makoto, et al.
Publicado: (2014)

Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE)
por: Yokota, Tomoya, et al.
Publicado: (2023)

Retrospective analysis of premedication, glucocorticosteroids, and H(1)-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
por: Ikegawa, Kiwako, et al.
Publicado: (2017)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014)

Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma
por: Hirano, Yasuhiro, et al.
Publicado: (2018)

Palliative Radiation Therapy for Macroscopic Hematuria Caused by Urothelial Cancer
por: Zhang, Haiqin, et al.
Publicado: (2020)

Validation of a Liquid Chromatography-Tandem Mass Spectrometric Assay for Quantitative Analysis of Lenvatinib in Human Plasma
por: Ogawa-Morita, Tomoko, et al.
Publicado: (2017)

Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab
por: Hane, Atsuya, et al.
Publicado: (2022)

Boosting of the enhanced permeability and retention effect with nanocapsules improves the therapeutic effects of cetuximab
por: Yang, Chao, et al.
Publicado: (2020)

Preoperative steroid for enhancing patients’ recovery after head and neck cancer surgery with free tissue transfer reconstruction: protocol for a phase III, placebo-controlled, randomised, double-blind study (J-SUPPORT 2022, PreSte-HN Study)
por: Shinozaki, Takeshi, et al.
Publicado: (2023)

Efficacy of radiation boost after breast-conserving surgery for breast cancer with focally positive, tumor-exposed margins
por: Suzuki, Ryoko, et al.
Publicado: (2020)

Establishment of a research policy for supportive and palliative care in Japan
por: Zenda, Sadamoto, et al.
Publicado: (2021)

Shapes of the uterine cavity are different in women with polycystic ovary syndrome
por: Fujii, Shunsaku, et al.
Publicado: (2023)

Age‐ and endometrial microbiota‐related delay in development of endometrial receptivity
por: Fujii, Shunsaku, et al.
Publicado: (2023)

KRAS mutations detected by the amplification refractory mutation system–Scorpion assays strongly correlate with therapeutic effect of cetuximab
por: Bando, H, et al.
Publicado: (2011)

Targeting EGFR and HER-2 with cetuximab- and trastuzumab-mediated immunotherapy in oesophageal squamous cell carcinoma
por: Kawaguchi, Y, et al.
Publicado: (2007)

Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial
por: Kiyota, Naomi, et al.
Publicado: (2022)

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux(® )and particle therapy]
por: Jensen, Alexandra D, et al.
Publicado: (2011)

A multicenter phase II trial of paclitaxel, carboplatin, and cetuximab followed by chemoradiotherapy in patients with unresectable locally advanced squamous cell carcinoma of the head and neck
por: Enokida, Tomohiro, et al.
Publicado: (2020)

Efficacy of mirtazapine for the treatment of fibromyalgia without concomitant depression: a randomized, double-blind, placebo-controlled phase IIa study in Japan
por: Miki, Kenji, et al.
Publicado: (2016)

Quality Assessment in Supportive Care in Head and Neck Cancer
por: Bonomo, Pierluigi, et al.
Publicado: (2019)

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08
por: Masuishi, Toshiki, et al.
Publicado: (2020)

HER2-targeted therapy should be shifted towards an earlier line for patients with anti-EGFR-therapy naïve, HER2-amplified metastatic colorectal cancer
por: Nakamura, Yoshiaki, et al.
Publicado: (2019)

Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study
por: Sakata, Hidenori, et al.
Publicado: (2022)

Dose–Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant Metastasis
por: Raturi, Vijay P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_339vm8sv1rdj15dd3bdtas2bof